Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24200,990,1.51 [1.35-1.69],3.5679298623419535e-13
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24112,193,2.29 [1.84-2.85],1.4584923306155486e-13
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26129,192,1.32 [1.03-1.70],0.0288123450740981
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18459,766,2.24 [1.97-2.54],2.1015649981102657e-36
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26060,123,1.41 [1.04-1.91],0.027096528957589
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,24988,83,2.15 [1.54-2.99],5.876185497182975e-06
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27508,122,1.38 [1.02-1.87],0.0381089302392124
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27502,82,1.31 [0.90-1.91],0.1523033385954541
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24361,65,2.15 [1.49-3.10],4.546660026512141e-05
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26825,120,2.02 [1.53-2.67],7.078947989550138e-07
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26776,71,2.30 [1.62-3.26],3.024557810904627e-06
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27586,78,1.31 [0.89-1.94],0.1732454487853504
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27552,100,1.30 [0.92-1.83],0.1345811036119451
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27547,95,1.35 [0.95-1.91],0.0910400267420078
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Mycoses,27201,62,2.06 [1.41-3.01],0.0001821922453461
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26384,436,1.61 [1.37-1.88],5.4348570739985646e-09
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26078,130,1.94 [1.47-2.54],2.140019921260685e-06
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26250,302,1.61 [1.33-1.95],9.69541141748388e-07
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22565,50,0.70 [0.39-1.23],0.2143578223732577
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22579,64,nan [nan-nan],
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22772,257,nan [nan-nan],
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",22780,265,0.88 [0.76-1.02],0.0829141637050625
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23190,675,1.04 [0.90-1.20],0.572952565976498
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22567,52,0.90 [0.53-1.52],0.6935885080518756
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24735,1027,1.49 [1.33-1.66],1.509883468898107e-12
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26507,294,1.09 [0.88-1.34],0.4465156513707272
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27243,109,1.11 [0.79-1.56],0.55069071954902
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27679,90,0.80 [0.53-1.20],0.2727163674888674
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm: Rectum,27460,59,1.56 [1.02-2.37],0.0389899238159016
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27679,70,0.75 [0.47-1.20],0.2322682613578282
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm: Stomach,27726,55,0.95 [0.57-1.58],0.8536825302591745
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign lipomatous neoplasm,27499,270,1.05 [0.84-1.31],0.688106417668749
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27673,106,0.94 [0.65-1.36],0.7466625660932222
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27674,107,1.04 [0.73-1.47],0.838858886777157
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27605,70,0.75 [0.47-1.20],0.2309895766044151
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Haemangioma, any site",27607,69,0.75 [0.46-1.21],0.2313389112743256
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Melanocytic naevi,27511,267,0.90 [0.71-1.14],0.3752974436238305
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27685,120,1.04 [0.74-1.46],0.8181389337922087
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Other benign neoplasms of skin,27574,229,1.08 [0.85-1.37],0.5310690322390279
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm of breast,27663,140,0.85 [0.61-1.17],0.3096972013439397
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Leiomyoma of uterus,27150,996,0.87 [0.77-0.98],0.0220891159961634
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26316,269,1.57 [1.28-1.92],1.4222914400280704e-05
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26040,447,1.53 [1.30-1.79],2.4962496268974855e-07
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26040,447,1.53 [1.30-1.79],2.4962496268974855e-07
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24481,408,1.78 [1.51-2.09],5.6915223729806455e-12
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27155,99,0.96 [0.66-1.41],0.8381604725994714
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27369,107,1.64 [1.20-2.23],0.0016874103920241
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22986,922,1.67 [1.48-1.87],9.474833470706534e-18
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,25383,899,1.42 [1.26-1.59],5.1581568499977436e-09
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25865,117,2.05 [1.54-2.73],1.033564102510175e-06
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26712,60,3.22 [2.29-4.51],1.3693769354875158e-11
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25853,105,2.06 [1.52-2.79],2.705624532207406e-06
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26164,416,2.40 [2.05-2.80],2.4961514665107593e-28
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26155,407,2.37 [2.03-2.78],3.2767072442239075e-27
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25630,197,1.33 [1.03-1.73],0.0272414347194739
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25633,194,1.35 [1.04-1.75],0.0219247613681627
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22790,726,1.59 [1.39-1.81],9.834687948354786e-12
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22145,81,1.87 [1.30-2.67],0.0006661786165107
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22739,675,1.56 [1.36-1.80],2.1373894740372483e-10
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22115,51,2.55 [1.71-3.80],4.580326145973435e-06
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",22134,70,1.72 [1.17-2.54],0.0062089205039941
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,Any mental disorder,23369,622,1.44 [1.25-1.65],2.700936209854139e-07
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22868,121,1.57 [1.17-2.11],0.0026287149304484
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27482,81,1.21 [0.84-1.75],0.306654117952144
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27525,49,1.41 [0.91-2.21],0.127266703367093
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26267,39,1.11 [0.64-1.93],0.7187115045207222
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27675,39,1.03 [0.59-1.79],0.9271666178189912
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22786,39,1.16 [0.66-2.03],0.6113453355823786
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,Alcohol dependence,26254,26,1.39 [0.75-2.59],0.292984427575038
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,Smoking dependency,26146,36,1.97 [1.22-3.17],0.0055084516208777
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22790,43,1.16 [0.69-1.97],0.5695293221143006
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23132,385,1.48 [1.25-1.76],7.871436142342739e-06
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,Depression,25700,342,1.38 [1.15-1.66],0.0005055712176066
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,Depression or dysthymia,22910,300,1.39 [1.14-1.70],0.0011118291722342
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",22896,149,1.35 [1.02-1.79],0.0366420507369746
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,Other anxiety disorders,25797,75,1.15 [0.77-1.72],0.4933605182417244
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Neurological diseases,23881,1639,1.17 [1.07-1.29],0.0006263429525744
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21841,184,1.03 [0.78-1.36],0.840919949969941
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27525,152,0.99 [0.74-1.35],0.9727158718020537
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26376,427,0.97 [0.81-1.17],0.7740270400783809
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Epilepsy,26088,139,0.73 [0.52-1.01],0.0609279041822387
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Migraine,26077,128,0.75 [0.53-1.07],0.1097772114581333
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27275,118,0.75 [0.52-1.08],0.120760422515514
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27019,60,1.31 [0.85-2.04],0.224655635260969
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other sleep disorders,26046,97,1.21 [0.85-1.72],0.2841820485360122
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Sleep apnoea,27307,70,0.98 [0.64-1.51],0.9416735504695783
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26329,858,1.15 [1.02-1.30],0.0262895177836522
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25590,119,1.46 [1.08-1.98],0.0136735033778905
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26017,546,1.02 [0.87-1.20],0.8075923287383096
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27463,76,1.03 [0.68-1.56],0.899934606872909
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Hemiplegia,27444,57,1.03 [0.64-1.67],0.9010470519059572
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other neurological diseases,27232,124,1.29 [0.94-1.76],0.1134068302818708
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26977,425,1.02 [0.85-1.22],0.8469541075844449
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26801,249,1.06 [0.84-1.34],0.6024871088104253
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26624,72,0.93 [0.60-1.46],0.7657390494741586
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26686,134,1.07 [0.78-1.46],0.6853152684258947
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26657,105,1.14 [0.81-1.62],0.4532643313106244
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23541,182,1.38 [1.06-1.78],0.0163141826943258
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23781,422,1.26 [1.06-1.51],0.0096079659835662
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26671,183,1.00 [0.76-1.32],0.9965896965804004
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27454,33,2.05 [1.22-3.44],0.0068021922129971
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1782,33,1.31 [0.73-2.34],0.3637434839445611
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25705,33,2.17 [1.30-3.64],0.003189296625722
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27006,92,1.06 [0.72-1.56],0.7705878003475137
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26967,53,1.22 [0.74-1.99],0.4328270908829228
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",26882,97,1.54 [1.10-2.16],0.011591978246744
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27140,105,1.06 [0.74-1.51],0.7452760570426553
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27600,129,1.68 [1.27-2.23],0.000325883096692
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,26919,106,1.25 [0.89-1.76],0.191273910127249
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20407,2804,1.75 [1.62-1.89],6.066140647457868e-44
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27140,77,1.87 [1.30-2.69],0.0007144512680736
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21447,2064,1.67 [1.53-1.82],9.865076692910435e-31
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Hypertension,21468,2085,1.70 [1.55-1.85],7.507712308289568e-33
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19432,49,4.61 [3.21-6.63],1.6300726045312263e-16
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26026,727,1.61 [1.41-1.83],4.0419355683359864e-13
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Angina pectoris,25804,505,1.56 [1.33-1.81],1.6979464167487982e-08
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27057,150,1.56 [1.19-2.03],0.0011557954720352
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27135,228,1.65 [1.34-2.05],3.839405209642408e-06
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27655,27,2.27 [1.34-3.88],0.0025015457630951
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25395,96,1.84 [1.33-2.54],0.0002086156178303
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25765,478,1.73 [1.48-2.01],2.127518034337364e-12
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26933,99,1.61 [1.16-2.25],0.0045673087590674
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27038,218,1.43 [1.14-1.80],0.0023028165972895
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26931,97,2.38 [1.76-3.21],1.3280410936339418e-08
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26931,97,2.38 [1.76-3.21],1.3280410936339418e-08
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19477,94,2.67 [1.98-3.61],1.6893112596272987e-10
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24069,40,2.82 [1.78-4.46],9.96734070498676e-06
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Conduction disorders,24110,81,1.49 [1.02-2.18],0.041287433284847
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16651,104,1.64 [1.17-2.30],0.0041851474436177
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16827,280,2.04 [1.66-2.50],1.0103972934737112e-11
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other arrhythmias,24079,50,1.46 [0.90-2.37],0.1244685900361476
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24086,57,1.65 [1.06-2.55],0.0255603334878101
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Heart failure, strict",26876,102,2.82 [2.13-3.75],7.250264474814744e-13
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26938,131,1.12 [0.82-1.53],0.4727264681888757
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26978,99,1.08 [0.75-1.55],0.6806035514369637
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27046,87,1.16 [0.79-1.69],0.4561236544579423
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26736,71,2.38 [1.69-3.33],5.512737672518255e-07
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26778,113,2.20 [1.67-2.90],2.4339969325607265e-08
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26100,133,1.34 [1.00-1.80],0.0511445361322313
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26073,106,1.30 [0.93-1.81],0.1248876745325393
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27515,103,1.25 [0.89-1.76],0.1938684093658206
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Varicose veins,26582,615,0.80 [0.68-0.94],0.0056481435660441
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Hypotension,26565,92,1.77 [1.27-2.46],0.0007494707116727
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22528,2121,1.69 [1.56-1.83],9.555786106553543e-39
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27507,132,1.35 [1.01-1.81],0.04370297085975
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26074,198,2.10 [1.69-2.60],2.3782647796248343e-11
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26055,179,2.11 [1.68-2.65],1.1859221071864342e-10
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26812,232,1.65 [1.33-2.04],4.022832872164168e-06
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26804,224,1.61 [1.30-2.00],1.7659337689764337e-05
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26947,569,1.38 [1.20-1.59],9.95199470450152e-06
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Chronic sinusitis,26492,114,1.96 [1.47-2.63],5.403274593664589e-06
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Nasal polyp,26460,82,1.28 [0.86-1.88],0.2213468861110022
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26738,360,1.23 [1.03-1.48],0.0251412251485625
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Deviated nasal septum,26520,142,1.34 [1.01-1.78],0.0452869909303431
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13342,65,1.70 [1.13-2.55],0.0109784195923025
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24741,1172,1.70 [1.54-1.88],3.216764716127061e-25
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Early onset COPD,26651,158,2.27 [1.80-2.86],4.240363726717048e-12
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26671,178,2.29 [1.84-2.86],1.4263212631541494e-13
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26671,178,2.29 [1.84-2.86],1.4263212631541494e-13
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25651,1008,1.51 [1.35-1.68],1.0700855577024357e-13
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Asthma,20585,1008,1.72 [1.54-1.92],1.5895685259275153e-21
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20393,1008,1.74 [1.56-1.94],2.9340309372074973e-22
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20570,993,1.72 [1.54-1.93],1.885832388130518e-21
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27395,84,2.39 [1.74-3.26],5.596422217261969e-08
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,25923,63,2.84 [2.01-4.01],3.044966311788852e-09
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27472,63,2.78 [1.97-3.92],6.7222128320469636e-09
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25916,56,2.66 [1.83-3.86],2.834778738961424e-07
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Pleural effusion,25861,88,2.01 [1.45-2.79],2.665044319622712e-05
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,25967,194,2.39 [1.94-2.95],4.412050536682076e-16
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26543,92,2.75 [2.07-3.66],4.098709553725469e-12
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19180,6051,1.35 [1.27-1.43],6.363616578934446e-23
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27147,472,1.21 [1.03-1.42],0.0208320200421095
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27680,103,0.83 [0.57-1.21],0.3420173802564996
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Impacted teeth,27685,93,0.78 [0.52-1.16],0.222662913408231
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Dental caries,26780,105,1.08 [0.76-1.52],0.6632925498384268
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26792,117,1.27 [0.93-1.75],0.1364205211875572
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27671,114,0.88 [0.62-1.26],0.4808943268710582
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26793,118,1.28 [0.93-1.76],0.1259423277527231
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26486,77,0.95 [0.62-1.46],0.8184003319961637
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27585,48,0.82 [0.47-1.43],0.489830543410256
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20932,221,1.12 [0.88-1.43],0.3665001699809893
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23046,2335,1.26 [1.16-1.36],1.0628075100354732e-08
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Oesophagitis,20999,288,1.54 [1.26-1.88],2.118584223243541e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21456,745,1.21 [1.06-1.39],0.0048518419207278
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20789,78,1.51 [1.04-2.20],0.0289442064233722
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20846,135,1.06 [0.77-1.46],0.7343028735074912
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20752,41,0.91 [0.49-1.66],0.7490902070518917
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Gastric ulcer,20860,149,1.07 [0.79-1.44],0.6563668383203534
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Duodenal ulcer,20784,73,1.01 [0.66-1.56],0.959432428262478
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27633,51,0.66 [0.38-1.16],0.1470456027709265
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Chronic gastritis,20848,137,1.50 [1.13-2.00],0.0054862005718791
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21565,854,1.36 [1.20-1.53],8.82045522202496e-07
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of appendix,27559,146,1.22 [0.91-1.64],0.1763905274749033
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Functional dyspepsia,21290,579,1.12 [0.96-1.31],0.1356395527095856
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20893,182,1.73 [1.35-2.21],1.246050045969895e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27594,143,1.12 [0.83-1.51],0.453438446570291
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Acute appendicitis,27530,117,1.22 [0.88-1.69],0.2315379665066065
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Hernia,24804,1209,1.27 [1.15-1.41],6.813581118346847e-06
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Inguinal hernia,23663,68,1.39 [0.92-2.11],0.1226438573858373
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Umbilical hernia,23668,73,0.88 [0.56-1.36],0.5529041896943122
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Ventral hernia,23705,110,1.45 [1.05-1.99],0.0237770547166481
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24560,965,1.29 [1.15-1.45],2.23988425456056e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26631,922,1.48 [1.32-1.66],1.0132940593842964e-11
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of intestines,21936,2216,1.25 [1.15-1.35],8.606034021408385e-08
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27368,64,2.01 [1.38-2.94],0.0002905305740981
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27652,93,1.70 [1.22-2.37],0.0017376526339453
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Crohn disease,25802,93,1.76 [1.26-2.45],0.0009110426293951
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25777,68,1.78 [1.21-2.61],0.0033094381452435
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27572,135,1.33 [0.99-1.79],0.0620421627830439
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Ulcerative colitis,25844,135,1.36 [1.01-1.84],0.0415712009619202
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25830,121,1.39 [1.02-1.91],0.0386520818273817
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26488,779,1.47 [1.30-1.66],8.009472612746574e-10
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26477,768,1.46 [1.29-1.65],3.0129662402144e-09
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19828,108,1.49 [1.08-2.06],0.0160370725078148
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Intestinal stricture,27244,108,1.40 [1.01-1.94],0.0444515246290793
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19787,67,1.21 [0.78-1.86],0.4009489056557909
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20399,679,1.42 [1.23-1.62],6.723548763932783e-07
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19967,247,1.42 [1.14-1.76],0.0016131625513342
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,20115,395,1.39 [1.16-1.65],0.0002704350051999
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Constipation,25998,351,1.33 [1.10-1.60],0.0029353912717563
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27197,123,1.17 [0.85-1.60],0.3425724486397336
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19845,125,1.02 [0.73-1.41],0.9153031490049036
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19768,48,1.30 [0.80-2.11],0.2904225043652618
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20622,902,1.17 [1.04-1.32],0.011905485589657
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of intestine,19955,235,1.39 [1.11-1.75],0.0040842059873898
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27180,106,1.05 [0.74-1.49],0.8049299086894612
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of liver,26923,105,1.60 [1.17-2.18],0.0034447898820714
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of liver,26872,54,0.89 [0.54-1.47],0.6437323263931125
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26137,889,1.22 [1.08-1.38],0.0010166259533646
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Cholelithiasis,25990,742,1.22 [1.07-1.39],0.0031189113844259
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Cholecystitis,25384,136,1.34 [1.00-1.80],0.0476521301839013
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25318,70,1.57 [1.06-2.33],0.0238727291019186
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis,25311,63,1.53 [1.01-2.32],0.0441333985866414
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27564,63,1.50 [0.99-2.29],0.0553276834584353
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26314,309,1.69 [1.40-2.03],3.113420460582754e-08
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26109,104,1.76 [1.28-2.42],0.0004904140142318
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Coeliac disease,26093,88,nan [nan-nan],
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26045,40,1.67 [1.01-2.77],0.0473612092645678
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26175,170,1.64 [1.28-2.11],9.258525078480058e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,GI-bleeding,26165,160,1.64 [1.27-2.12],0.0001393781505054
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24544,1628,1.11 [1.01-1.22],0.0240283966850456
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27257,116,1.23 [0.89-1.70],0.2088433157518724
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27256,458,0.94 [0.79-1.12],0.4879608004426083
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26135,700,1.02 [0.88-1.17],0.8091284055651188
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26889,325,1.43 [1.19-1.73],0.0001546123759075
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26635,71,1.16 [0.77-1.74],0.4910476062769323
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26771,207,1.54 [1.23-1.94],0.0002073454829869
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27428,91,1.63 [1.17-2.29],0.0043871569297405
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27400,63,1.95 [1.33-2.85],0.0006380218459051
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27387,50,2.02 [1.32-3.09],0.00119373790739
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27446,56,0.70 [0.41-1.21],0.2007018308657638
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27443,53,0.67 [0.38-1.18],0.1645246746159868
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26857,59,1.70 [1.13-2.57],0.0114722712165507
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27156,358,0.87 [0.71-1.06],0.1612506286735775
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25538,103,1.42 [1.01-1.98],0.0418836267245712
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25593,158,0.84 [0.62-1.15],0.2806765303647353
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25549,114,0.80 [0.55-1.15],0.2272523330263189
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25691,256,0.92 [0.73-1.17],0.5145584557833471
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25665,230,0.88 [0.69-1.14],0.342260732216473
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19527,4435,1.36 [1.28-1.45],2.9506221389244306e-21
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21272,2555,1.35 [1.25-1.46],3.5384179028444294e-14
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,24885,1344,1.25 [1.13-1.38],8.569352056540869e-06
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18927,210,2.65 [2.15-3.26],3.3131830730090505e-20
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19240,523,1.99 [1.73-2.31],1.0419475748197114e-20
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27133,202,2.49 [2.03-3.06],2.2553972039220484e-18
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27150,184,2.57 [2.08-3.18],2.2749567098932005e-18
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19953,1236,1.37 [1.23-1.53],1.8506839215110452e-08
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22689,1236,1.32 [1.18-1.47],5.952860514684119e-07
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18729,12,3.91 [1.87-8.18],0.0002869876220556
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27518,12,3.39 [1.61-7.13],0.0012875920889617
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18999,282,1.66 [1.36-2.04],9.028576246999586e-07
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18804,87,1.40 [0.95-2.05],0.0855986299872014
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19024,307,1.32 [1.07-1.63],0.0103238692694289
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27520,156,1.15 [0.86-1.53],0.3462165728296993
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19207,490,1.17 [0.99-1.39],0.0737105334312669
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19208,491,1.66 [1.41-1.94],5.974009982201328e-10
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20147,1430,1.17 [1.05-1.29],0.003028593133071
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18825,108,1.32 [0.93-1.87],0.1194561861687077
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19145,428,0.99 [0.82-1.20],0.9394252713122088
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18799,82,0.84 [0.54-1.31],0.4424481693618139
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18825,108,1.46 [1.03-2.06],0.0315657339754054
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19095,378,1.14 [0.94-1.38],0.1720950001136353
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19038,321,1.11 [0.91-1.37],0.3063894059925651
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20655,299,1.26 [1.02-1.54],0.028707805217025
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26891,221,1.97 [1.59-2.43],3.3470574651586016e-10
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26762,92,3.75 [2.86-4.92],1.3555428446740598e-21
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23717,84,2.08 [1.47-2.94],3.6718944067106414e-05
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,23941,308,1.57 [1.30-1.91],4.505823143116312e-06
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24663,1030,1.32 [1.18-1.48],1.1767918039527737e-06
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23850,217,1.61 [1.28-2.03],4.47052090133496e-05
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23711,78,1.38 [0.93-2.04],0.1054445420478711
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24451,818,1.23 [1.09-1.40],0.0011194414273629
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23682,49,1.14 [0.69-1.89],0.6142487733393744
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23876,243,1.39 [1.11-1.73],0.00387939148895
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23735,102,1.66 [1.20-2.30],0.0021022729410377
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23725,92,0.98 [0.67-1.44],0.920758973824119
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23797,164,1.07 [0.80-1.42],0.6510612979423309
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23707,74,1.54 [1.04-2.29],0.0302449489125243
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23989,356,1.29 [1.07-1.56],0.0064764015047122
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23925,384,1.10 [0.91-1.33],0.3145038449974072
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23613,72,1.62 [1.10-2.37],0.0140506109735258
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23651,110,1.06 [0.75-1.52],0.7267755353340022
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23683,142,1.09 [0.80-1.48],0.6001462893707965
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23580,39,1.10 [0.62-1.94],0.742912901229357
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23600,59,1.28 [0.81-2.02],0.2936273644688854
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23584,43,1.16 [0.67-2.01],0.6043409117261759
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23823,282,1.31 [1.06-1.61],0.0108942489095344
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23602,61,1.37 [0.89-2.11],0.1577664759118822
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23609,68,1.13 [0.73-1.73],0.5870420037313864
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23681,140,1.52 [1.15-2.01],0.002902802685434
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23623,82,0.89 [0.58-1.35],0.5815043530318378
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24087,546,1.37 [1.18-1.59],2.4361039086028603e-05
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23734,193,1.40 [1.10-1.78],0.0070341293279142
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23835,294,1.42 [1.17-1.73],0.0003886223827161
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,24948,239,1.63 [1.31-2.03],1.0209714458049868e-05
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,25202,493,1.39 [1.18-1.63],4.8115836796936806e-05
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24749,40,1.40 [0.82-2.41],0.2169879670601413
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24777,68,1.16 [0.75-1.81],0.4986408075536402
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24828,119,1.08 [0.77-1.51],0.6684558293452048
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22626,6156,1.15 [1.09-1.22],6.323214781858561e-07
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25241,202,2.88 [2.36-3.51],1.8509170622908239e-25
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25085,46,2.13 [1.36-3.33],0.0009057538223076
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Acute renal failure,25416,34,4.14 [2.74-6.27],1.9003407216627947e-11
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25431,49,4.69 [3.33-6.59],6.558544907445207e-19
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25423,41,3.75 [2.54-5.53],2.806370576241468e-11
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27475,133,1.27 [0.94-1.71],0.1265986385365515
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27351,68,2.00 [1.39-2.89],0.0002081275153447
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27442,100,1.37 [0.97-1.92],0.0742043352794539
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27380,38,0.93 [0.50-1.72],0.8215198679200078
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25474,1253,1.28 [1.16-1.42],1.6442467408760682e-06
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Cystitis,24358,137,1.83 [1.39-2.40],1.3796744032446276e-05
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24308,87,1.32 [0.91-1.92],0.1407762332860519
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24389,168,1.46 [1.12-1.90],0.0047690968738285
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24310,89,1.11 [0.75-1.63],0.6053846256342614
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25207,986,1.28 [1.14-1.44],2.3176011975591183e-05
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27404,483,1.12 [0.95-1.32],0.1697430156349433
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27071,150,0.98 [0.72-1.33],0.9152750966444616
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27092,171,1.30 [1.00-1.70],0.0542428216164873
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27035,114,1.12 [0.80-1.56],0.5141546548120324
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27343,560,1.15 [0.99-1.34],0.0669503767218016
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26916,133,1.01 [0.73-1.39],0.9675911360092312
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27034,251,1.20 [0.96-1.49],0.1147375966518995
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25272,4608,0.97 [0.91-1.03],0.2598327370389924
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Endometriosis,21027,363,0.93 [0.77-1.13],0.4855056224433917
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20761,97,0.92 [0.63-1.34],0.6612232506461159
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20834,170,1.12 [0.85-1.47],0.408592884895409
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21464,800,1.01 [0.88-1.16],0.8658248678432585
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21075,411,1.04 [0.87-1.25],0.6365775434279606
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21627,963,0.89 [0.78-1.01],0.0640630744056363
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20981,317,0.82 [0.66-1.02],0.0777077115266243
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21105,441,1.05 [0.88-1.25],0.573031011254122
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20764,100,0.65 [0.43-0.98],0.0380696922311615
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20854,190,1.10 [0.85-1.43],0.4706094384946687
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27679,268,1.15 [0.92-1.43],0.2174545837613669
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27691,254,1.14 [0.91-1.43],0.2400006812035098
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27716,141,1.16 [0.86-1.57],0.3256370805519387
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27705,155,1.15 [0.87-1.53],0.333801806134183
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20806,142,0.92 [0.67-1.26],0.5831441839118041
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20779,115,0.92 [0.65-1.31],0.6390821955119492
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20808,144,1.05 [0.78-1.43],0.7406450808250646
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Irregular menses,27613,468,0.95 [0.80-1.13],0.5505731471256858
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22004,1340,0.88 [0.79-0.98],0.0197775923962451
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21537,873,0.87 [0.77-1.00],0.0425930109707739
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27699,197,1.04 [0.80-1.35],0.7709338597082988
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21136,472,0.93 [0.78-1.10],0.3836554011662542
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20993,329,0.85 [0.69-1.05],0.1376301223313054
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21564,900,1.03 [0.90-1.16],0.701516280099586
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Female infertility,20780,116,1.11 [0.79-1.56],0.5372673927317857
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20773,109,1.07 [0.75-1.52],0.7010135154506333
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27713,881,0.95 [0.82-1.09],0.4294318489364221
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27717,1202,0.95 [0.84-1.07],0.3996246516735079
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27714,480,0.90 [0.76-1.08],0.263581166593769
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27370,136,0.70 [0.49-0.99],0.0451249029971903
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27426,192,1.05 [0.80-1.37],0.7402091974963991
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27400,166,0.88 [0.66-1.17],0.3769368800570506
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27732,166,0.86 [0.64-1.16],0.3182346058206209
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27734,164,0.84 [0.62-1.14],0.2619883082547111
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27731,417,0.89 [0.73-1.07],0.2116000493602566
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27440,126,0.78 [0.55-1.10],0.153098220985307
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27544,230,0.92 [0.72-1.18],0.5057413794503214
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26981,149,0.92 [0.67-1.26],0.5864562906387807
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27036,204,0.90 [0.69-1.18],0.4575936674779336
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27083,251,0.98 [0.77-1.25],0.8853260124797312
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26980,148,1.24 [0.91-1.68],0.170226984619221
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26971,139,1.07 [0.78-1.47],0.6728422110228445
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26980,148,0.68 [0.49-0.95],0.024093830977101
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26747,232,0.93 [0.72-1.21],0.6019105587196003
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26950,435,1.11 [0.92-1.33],0.2658665588510622
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27185,670,0.96 [0.82-1.13],0.5996074957068624
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27735,171,1.00 [0.75-1.33],0.9779285566580932
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26271,130,1.00 [0.72-1.40],0.9988362239245284
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26618,103,0.74 [0.50-1.11],0.1447488600432468
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27743,343,0.87 [0.70-1.08],0.1991690974035278
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27660,260,0.76 [0.59-0.98],0.0316097857685866
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27730,253,1.15 [0.92-1.45],0.2252398661257625
TGFA,Protransforming growth factor alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27720,243,1.20 [0.95-1.51],0.1277294731046798
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27441,44,0.90 [0.51-1.58],0.7198530660659217
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24798,646,0.96 [0.83-1.12],0.6203717195502465
